SCHEMBL3146702

SCHEMBL3146702

CC1CCC2C(C)(C)CCCC2(C)C1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 4/20 0.42
PIK3CG P48736 4/20 0.42
CETP P11597 3/20 0.40
CYP19A1 P11511 2/20 0.40
PTGS2 P35354 1/20 0.40
ALOX5 P09917 1/20 0.40
ALOX15 P16050 1/20 0.40
ALOX12 P18054 1/20 0.40
TSHR P16473 2/20 0.38
CYP3A4 P08684 3/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
TP53 P04637 2/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA7 P36544 1/20 0.35
CHRNA4 P43681 1/20 0.35
USP2 O75604 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17394853 0.78 PIK3CA (0.42) PIK3CAPIK3CGCETPCYP19A1PTGS2
SCHEMBL17394844 0.78 PIK3CA (0.42) PIK3CAPIK3CGCETPCYP19A1PTGS2
SCHEMBL21917264 0.73 CYP19A1 (0.49) CETPCYP19A1ALOX5ALOX15ALOX12
SCHEMBL14880005 0.73 CYP19A1 (0.49) CETPCYP19A1ALOX5ALOX15ALOX12
SCHEMBL266913 0.72 CYP19A1 (0.44) CETPCYP19A1ALOX5ALOX15ALOX12
SCHEMBL9418499 0.72 CYP19A1 (0.40) CYP19A1TSHRKDM4EMEN1KMT2A
SCHEMBL9418494 0.72 CYP19A1 (0.40) CYP19A1TSHRKDM4EMEN1KMT2A
SCHEMBL3146912 0.72 CYP19A1 (0.44) CETPCYP19A1ALOX5ALOX15ALOX12
SCHEMBL3536691 0.71 CA1 (0.38) PIK3CAPIK3CGCETPCYP19A1PTGS2
SCHEMBL16637469 0.71 TSHR (0.36) PIK3CAPIK3CGCETPCYP19A1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101223123-B Naphthalenone derivative with powdery-ionone type odours FIRMENICH S.A. (CH) 2011-11-30 CN disclosed
EP-1910262-B1 NAPHTHALENONE DERIVATIVE WITH POWDERY-IONONE TYPE ODOURS FIRMENICH & CIE (CH) 2010-03-03 EP disclosed
US-20080214419-A1 Naphthalenone Derivative with Powdery-Ionone Type Odors FIRMENICH SA (CH) 2008-09-04 US disclosed
CN-101223123-A Naphthalenone derivative with powdery-ionone type odours FIRMENICH & CIE (CH) 2008-07-16 CN disclosed
EP-1910262-A1 NAPHTHALENONE DERIVATIVE WITH POWDERY-IONONE TYPE ODOURS FIRMENICH SA (CH) 2008-04-16 EP disclosed
WO-2007010420-A1 NAPHTHALENONE DERIVATIVE WITH POWDERY-IONONE TYPE ODOURS FIRMENICH SA (CH) 2007-01-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214419-A1 Naphthalenone Derivative with Powdery-Ionone Type Odors IPO5, TRPA1, SCN5A PIK3CA 3046/4885PIK3CG 2930/4885CETP 1614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.